ATE378071T1 - Endgruppenverzweigte polymere verbindungen und diese enthaltende polymere konjugate - Google Patents

Endgruppenverzweigte polymere verbindungen und diese enthaltende polymere konjugate

Info

Publication number
ATE378071T1
ATE378071T1 AT02709573T AT02709573T ATE378071T1 AT E378071 T1 ATE378071 T1 AT E378071T1 AT 02709573 T AT02709573 T AT 02709573T AT 02709573 T AT02709573 T AT 02709573T AT E378071 T1 ATE378071 T1 AT E378071T1
Authority
AT
Austria
Prior art keywords
polymeric
branched
containing same
conjugates containing
disclosed
Prior art date
Application number
AT02709573T
Other languages
English (en)
Inventor
Yun Choe
Richard Greenwald
Original Assignee
Enzon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enzon Inc filed Critical Enzon Inc
Application granted granted Critical
Publication of ATE378071T1 publication Critical patent/ATE378071T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polyethers (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02709573T 2001-02-20 2002-02-19 Endgruppenverzweigte polymere verbindungen und diese enthaltende polymere konjugate ATE378071T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27251101P 2001-02-20 2001-02-20

Publications (1)

Publication Number Publication Date
ATE378071T1 true ATE378071T1 (de) 2007-11-15

Family

ID=23040108

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02709573T ATE378071T1 (de) 2001-02-20 2002-02-19 Endgruppenverzweigte polymere verbindungen und diese enthaltende polymere konjugate

Country Status (9)

Country Link
US (1) US20020161052A1 (de)
EP (1) EP1361895B1 (de)
JP (1) JP2004530736A (de)
AT (1) ATE378071T1 (de)
CA (1) CA2437986A1 (de)
DE (1) DE60223496T2 (de)
DK (1) DK1361895T3 (de)
MX (1) MXPA03007391A (de)
WO (1) WO2002066066A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6624142B2 (en) * 1997-12-30 2003-09-23 Enzon, Inc. Trimethyl lock based tetrapartate prodrugs
US7332164B2 (en) * 2003-03-21 2008-02-19 Enzon Pharmaceuticals, Inc. Heterobifunctional polymeric bioconjugates
EP1533385A1 (de) * 2003-09-05 2005-05-25 Nuevolution A/S Matrizenabhängigen Verbindungen zur Herstellung von kodierten Molekülen und gesteuerten Verfahren unter Verwendung dieser Verbindungen
JP4820758B2 (ja) 2004-09-22 2011-11-24 日本化薬株式会社 新規ブロック共重合体、ミセル調製物及びそれを有効成分とする抗癌剤
BRPI0611872B8 (pt) 2005-06-16 2021-05-25 Nektar Therapeutics reagente polimérico, conjugado, método para preparação de um conjugado e composição farmacêutica
WO2007111211A1 (ja) 2006-03-28 2007-10-04 Nippon Kayaku Kabushiki Kaisha タキサン類の高分子結合体
RU2447095C2 (ru) 2006-05-18 2012-04-10 Ниппон Каяку Кабусики Кайся Высокомолекулярный конъюгат подофиллотоксинов
CA2658100A1 (en) * 2006-07-19 2008-01-24 Nippon Kayaku Kabushiki Kaisha High-molecular weight conjugate of combretastatins
WO2008056596A1 (fr) 2006-11-06 2008-05-15 Nippon Kayaku Kabushiki Kaisha Dérivé polymère d'un antagoniste métabolique d'acide nucléique
EP2090607B1 (de) 2006-11-08 2015-05-20 Nippon Kayaku Kabushiki Kaisha Polymerderivat eines nukleinsäuremetabolismus-antagonisten
CN101808651B (zh) 2007-09-28 2013-03-27 日本化药株式会社 类固醇类的高分子结合物
CN101977631A (zh) 2008-03-18 2011-02-16 日本化药株式会社 生理活性物质的高分子量偶联物
US9149540B2 (en) 2008-05-08 2015-10-06 Nippon Kayaku Kabushiki Kaisha Polymer conjugate of folic acid or folic acid derivative
US8808749B2 (en) 2009-05-15 2014-08-19 Nippon Kayaku Kabushiki Kaisha Polymer conjugate of bioactive substance having hydroxy group
JP5856069B2 (ja) 2010-11-17 2016-02-09 日本化薬株式会社 新規なシチジン系代謝拮抗剤の高分子誘導体
KR101849142B1 (ko) 2011-09-11 2018-04-16 니폰 가야꾸 가부시끼가이샤 블록 공중합체의 제조방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552391A (en) * 1990-01-16 1996-09-03 La Jolla Pharmaceutical Company Chemically-defined non-polymeric valency platform molecules and conjugates thereof
WO1993024476A1 (en) * 1992-06-04 1993-12-09 Clover Consolidated, Limited Water-soluble polymeric carriers for drug delivery
US5880131A (en) * 1993-10-20 1999-03-09 Enzon, Inc. High molecular weight polymer-based prodrugs
US5840900A (en) * 1993-10-20 1998-11-24 Enzon, Inc. High molecular weight polymer-based prodrugs
US5965566A (en) * 1993-10-20 1999-10-12 Enzon, Inc. High molecular weight polymer-based prodrugs
US6011042A (en) * 1997-10-10 2000-01-04 Enzon, Inc. Acyl polymeric derivatives of aromatic hydroxyl-containing compounds
US6180095B1 (en) * 1997-12-17 2001-01-30 Enzon, Inc. Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
US5965119A (en) * 1997-12-30 1999-10-12 Enzon, Inc. Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
US6153655A (en) * 1998-04-17 2000-11-28 Enzon, Inc. Terminally-branched polymeric linkers and polymeric conjugates containing the same

Also Published As

Publication number Publication date
DE60223496T2 (de) 2008-10-02
WO2002066066A1 (en) 2002-08-29
EP1361895A4 (de) 2005-01-19
US20020161052A1 (en) 2002-10-31
DK1361895T3 (da) 2008-02-18
JP2004530736A (ja) 2004-10-07
CA2437986A1 (en) 2002-08-29
WO2002066066A9 (en) 2003-10-16
EP1361895B1 (de) 2007-11-14
DE60223496D1 (de) 2007-12-27
MXPA03007391A (es) 2003-12-04
EP1361895A1 (de) 2003-11-19

Similar Documents

Publication Publication Date Title
DE60223499D1 (de) Terminal verzweigte, polymere linker und diese enthaltende polymere konjugate
ATE378071T1 (de) Endgruppenverzweigte polymere verbindungen und diese enthaltende polymere konjugate
CY1121983T1 (el) Παραγωγο ραπαμυκινης για τη θεραπευτικη αντιμετωπιση καρκινου του παγκρεατος
NO20013451L (no) 1-Heterocyklus-substituerte diarylaminer
NO20050525L (no) Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer
TR200101103T2 (tr) CGMP PDE-İnhibitörü içeren kontrollu serbest bırakılan farmasötik formülasyonlar
DE60022866D1 (de) Bizyklische heterozyklen, diese verbindungen enthaltende zusammenstellungen und verfahren zu deren herstellung
PT1200412E (pt) Agentes anti-proliferativos de imidazole
DK1093819T3 (da) Forbindelse og præparat til tilförsel af aktive midler
MY136520A (en) Novel compounds
CY1112743T1 (el) Στερεοϊσομερως εμπλουτισμενες ενωσεις 3-αμινοκαρβονυλ δικυκλοεπτενο πυριμιδινοδιαμινης και οι χρησεις τους
DE60314633D1 (de) Substituierte 1,3-diphenylprop-2-en-1-on derivate, deren herstellung und anwendungen
PT1948155E (pt) Composições farmacêuticas contendo droxidopa
DE60321965D1 (de) Amidfunktionelle polymere, zusammensetzungen und verfahren
WO2007059008A3 (en) N-substituted indenoisoquinolines and syntheses thereof
NO20023161D0 (no) Substituerte piperidiner, legemidler inneholdende disse forbindelser og fremgangsmåter for fremstilling av dem
BR0209695A (pt) Conjugados de lipìdeo-polìmero
TR199901104T2 (xx) Farmas�tik bile�ikler.
DE69907926D1 (de) 1,2,4-triazol-3-thion verbindungen
IL157540A0 (en) N-(aryl)-2-arylethenesulphonamides and therapeutic uses thereof
DE602006003617D1 (de) Zusammensetzungen enthaltend Levetiracetam und Verfahren zu deren Herstellung.
WO2005089294A3 (en) Synthesis of indenoisoquinoliniums and methods of use
DE69918711D1 (de) Amphiphile polyamin verbindungen
DE60204083D1 (de) N-Benzylpiperazin N-benzylpiperazine, Verbindungen, Verfahren zu deren Herstellung und deren pharmazeutischen Zusammensetzungen
WO2001032216A3 (fr) Produit comprenant au moins une substance inhibitrice des no synthases en association avec au moins une substance inhibitrice des phospholipases a2

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties